Tumor-infiltrating lymphocytes (TILs), in general, and notably CD8+ TILs, are associated with a favourable prognosis in non-small cell lung cancer (NSCLC) (Gueguen et al., 2021). This evidence concerns the gene CD8A and non-small cell lung carcinoma.